文献速递前列腺癌

代谢综合征与前列腺癌的Meta分析

Meta-analysis of metabolic syndrome and prostate cancer.
PubMed 文献 · Prostate Cancer Prostatic Dis · 2017-02-21

该系统评价与Meta分析检索截至2015年9月的多个数据库,纳入24项研究共132589名参与者(17.35%有代谢综合征),评估代谢综合征及其组分与前列腺癌发病、高级别前列腺癌及侵袭性病理特征和生化复发的关联。

要点

  • 代谢综合征与病理Gleason评分≥8、包膜外侵犯、精囊侵犯、手术切缘阳性及生化复发均相关。

核心结论

  • 代谢综合征的存在与前列腺癌患者更差的肿瘤学结局相关,尤其是更具侵袭性的肿瘤特征和生化复发。

研究设计与样本

  • 系统文献检索与Meta分析,由2名独立评价者检索PubMed、EMBASE、Cochrane和Academic One File数据库截至2015年9月,最终纳入24项研究共132589名参与者,其中17.35%有代谢综合征。

主要发现

  • 除高血压外,未发现代谢综合征各组分与前列腺癌风险存在关联。

局限性

  • 研究间存在统计学异质性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Metabolic syndrome (MetS) and prostate cancer (PCa) are highly prevalent conditions worldwide. Current evidence suggests the emerging hypothesis that MetS could play a role in the development and progression of several neoplasms. The aims of this study are to evaluate the impact of MetS and MetS factors on PCa incidence, on the risk of high-grade PCa and to analyze the role of MetS and single MetS components on the development of aggressive PCa features. METHODS: A systematic literature search and analysis on PubMed, EMBASE, Cochrane and Academic One File databases until September 2015 was performed by 2 independent reviewers to evaluate the associations between MetS and PCa incidence, and between MetS and high-grade PCa incidence (bioptical Gleason Score⩾8, Prognostic Group 4-5 according to the novel prostate cancer grading system). Also the association between MetS and individual MetS components with pathological Gleason Score⩾8, extra-capsular extension, seminal vesicle invasion, positive surgical margins and biochemical recurrence (defined as two consecutive PSA values ⩾0.2 ng ml-1 after radical prostatectomy) was evaluated. RESULTS: 24 studies were selected including a total of 132 589 participants of whom 17.35% had MetS. There was a slight association between MetS and PCa incidence (odds ratio (OR)=1.17 (1.00-1.36), P=0.04) and between high-grade PCa and MetS (OR= 1.89 (1.50-2.38), P<0.0001) but the studies were statistically heterogeneous. No association was found between MetS components and PCa risk except for hypertension. MetS was significantly associated with pathologic Gleason Score⩾8 (OR= 1.77 (1.34-2.34); P<0.01), extra-capsular extension (OR=1.13 (1.09-1.18); P<0.01), seminal vesicle invasion (OR=1.09 (1.07-1.12); P<0.01), positive surgical margins (OR=1.67 (1.47-1.91); P<0.01) and biochemical recurrence (OR=1.67 (1.04-2.69); P<0.01). CONCLUSIONS: The presence of MetS is associated with worse oncologic outcomes in men with PCa, in particular with more aggressive tumor features, and biochemical recurrence.

来源:Prostate Cancer Prostatic Dis,查看原文。版权归原作者所有。

引用

  1. Gacci M, Russo GI, De Nunzio C, et al. Meta-analysis of metabolic syndrome and prostate cancer. Prostate Cancer Prostatic Dis. 2017. PMID: 28220805. doi:10.1038/pcan.2017.1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。